#

NTAGI

Government Calls For Aggressive Genome Sequencing As Covid Cases Spike In Asia, Europe

Covid-19 Vaccination For 12-14 Age Group In India To Start Soon. Here's What NTAGI Chief Said
Covaxin Showed Good Immune Response In Children, Slightly Better Than Adults: NTAGI Chief
No Consensus Or Final Recommendation By NTAGI On Additional Covid Vaccine Dose, Inoculation Of Kids
Additional Covid Dose For Immunocompromised & Paediatric Vaccination: NTAGI To Take Call Today Amid Omicron Threat
Omicron Scare: NTAGI To Meet On Monday To Discuss Additional Vaccine Dose, Child Immunisation

Single Dose Of Covishield 61% Effective; Will Revisit Vaccine Interval With Fresh Data: NTAGI Chief

About us | Advertisement| Privacy policy

© Copyright@2024.ABP Network Private Limited. All rights reserved.